Oncology & Cancer
Biomarker predicts risk of breast cancer recurrence after tamoxifen treatment
A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after ...
Jun 29, 2013
0
0